By Professor Maree Hackett

Preprints

Hankey G; Hackett ML; Almeida OP; Flicker L; Mead GE; Dennis MS; Etherton-Beer C; Ford AH; Billot L; Jan S; Lundström E; Anderson CS; Thang-Nguyen H; Gommans J; Yi Q, Effects of Fluoxetine on Functional Recovery after Acute Stroke (AFFINITY): A Randomised, Double-Blind, Placebo-Controlled Trial, http://dx.doi.org/10.2139/ssrn.3559565

Loo C; Glozier N; Barton D; Baune B; Mills N; Fitzgerald PB; Glue P; Sarma S; Galvez-Ortiz V; Hadzi-Pavlovic D; Alonzo A; Dong V; Martin DM; Nikolin S; Mitchell P; Berk M; Carter G; Hackett M; Leyden J; Hood S; Somogyi A; Lapidus K; stratton E; Lyrtzis E; Gainsford K; Neehoff S; Garg D; Thornton N; Fourrier C; Richardson K; Rozakis D; Scaria A; Mihalopoulos C; Chatterton ML; McDonald W; Boyce P; Holtzheimer P; Kozel FA; Riva-Posse P; Rodgers A, Efficacy and Safety of Repeated Subcutaneous Ketamine Injections for Treatment Resistant Depression - The KADS Study: A Randomised, Double-Blind, Comparator-Controlled Trial, http://dx.doi.org/10.2139/ssrn.4107711

Mead G; Legg L; Tilney R; Fang Hsieh C; Wu S; Lundströ m E; Rudberg AS; Kutlubaev M; Dennis MS; Soleimani B; Barugh A; Hackett ML; Hankey GJ, Fluoxetine for Improving Functional Outcome After Stroke: A Systematic Review and Meta-Analysis of Randomised Controlled Trials, http://dx.doi.org/10.2139/ssrn.3264978

Other

Loo C; Somogyi A; Alonzo A; Rodgers A; Baune B; Mihalopoulos C; Barton D; Hadzi-Pavlovic D; Martin D; Carter G; Leyden J; Lapidus K; Hackett M; Chatterton ML; Berk M; Mills N; Glozier N; Fitzgerald P; Glue P; Mitchell P; Hood S; Nikolin S; Dong V; Galvez-Ortiz V, 2021, Ketamine therapy among patients with treatment-resistant depression: a double-blind, randomised, controlled trial (The KADS Trial) - Clinical Trial Protocol & Statistical Analysis Plan, http://dx.doi.org/10.17605/OSF.IO/6FPGU

Back to profile page